Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-17-023343

Options or other derivatives

  • Director acquired 1,104 shares (other)

From the SEC's structured data for this filing

Trades in this filing

KIRK RANDAL J · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-05-31 Other acquisition : show line 1 in the form Series 1 Preferred Stock +1,104 111,598 I
Loading xslF345X03/doc1.xml…